Click here for slides on this topic


Ezetimibe

A cholesterol-absorption inhibitor used to treat elevated cholesterol.
The following content matched the glossary term: Ezetimibe

NDEI.org Expert Commentary Silvio Inzucchi MD on IMPROVE-IT Subanalysis CV Benfits of Ezetimibe Exclusive to Subjects With Diabetes

Top

Silvio Inzucchi, MD, provides expert commentary on data from a subanalysis of IMPROVE-IT that showed the cardiovascular benefits of ezetimibe are restricted to patients with type 2 diabetes; from ESC Congress 2015.

CV Benefits of Ezetimibe Favor Patients With Type 2 Diabetes in IMPROVE-IT Analysis

Top

Data from a subanalysis of IMPROVE-IT at ESC Congress 2015 show that the cardiovascular benefits of ezetimibe are exclusive to individuals with type 2 diabetes. Includes expert commentary.

OnsiteInsight November 2012

Top

The latest diabetes literature exploring diabetes guidelines, diabetes treatment, diabetes management, and diabetes prevention with commentary from diabetes experts.

International Diabetes Federation (IDF) Guidelines 2012 - Screening & Diagnosis

Top

Diabetes management guidelines from the International Diabetes Federation (IDF) 2012 



Slide Library Results

Search Results for: Ezetimibe Slides Found: 16
HPS2-THRIVE: Niacin +Laropiprant for Vascular Risk Reduction
HPS2-THRIVE: Baseline Characteristics
AIM-HIGH: Design
ACC/AHA Cholesterol Guidelines 2013: Nonstatin Safety Recommendations: Bile-Acid Sequestrants & Ezetimibe
IDF Type 2 Diabetes Guidelines CVD Risk Reduction Treatment | NDEI
IMPROVE-IT Ezetimibe Simvastatin Reduces CV Events Type 2 Diabetes | NDEI
Ezetimibe/Simvastatin Reduces MI & Stroke Type 2 Diabetes IMPROVE-IT | NDEI
Combo Ezetimibe/Simvastatin LDL-C Type 2 Diabetes IMPROVE-IT | NDEI
GAUSS-3 Evolocumab Reduces LDL-C in Statin-Intolerant Patients | NDEI
GAUSS-3 Absolute LDL-C Reduction With Evolocumab Statin Intolerance | NDEI
GAUSS-3: LDL-C Goal Achievement With Evolocumab Statin Intolerance | NDEI
GAUSS-3 Evolocumab Effects on Lipoproteins in Statin-Intolerant Patients | NDEI
GAUSS-3 Evolocumab Use in Statin-Intolerant Patients Muscle Symptoms | NDEI
GAUSS-3 Muscle-Related Adverse Events With Evolocumab & Ezetimibe | NDEI
GAUSS-3 Design Evolocumab Vs Ezetimibe in Statin Intolerance | NDEI
Pharmacotherapy for Dyslipidemia in Older Adults NLA Cholesterol Guidelines